BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 35877268)

  • 21. Awareness, knowledge and attitudes to basal cell carcinoma and actinic keratoses among the general public within Europe.
    MacKie RM
    J Eur Acad Dermatol Venereol; 2004 Sep; 18(5):552-5. PubMed ID: 15324391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progression of actinic keratosis to squamous cell carcinoma revisited: clinical and treatment implications.
    Feldman SR; Fleischer AB
    Cutis; 2011 Apr; 87(4):201-7. PubMed ID: 21644496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Actinic keratosis: a cross-sectional study of disease characteristics and treatment patterns in Danish dermatology clinics.
    Erlendsson AM; Egekvist H; Lorentzen HF; Philipsen PA; Stausbøl-Grøn B; Stender IM; Haedersdal M
    Int J Dermatol; 2016 Mar; 55(3):309-16. PubMed ID: 26276415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimizing management of actinic keratosis and photodamaged skin: utilizing a stepwise approach.
    Lee AD; Jorizzo JL
    Cutis; 2009 Sep; 84(3):169-75. PubMed ID: 19842577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of sunscreen with photolyase or regular sunscreen associated with topical antioxidants in treating advanced photodamage and cutaneous field cancerization: a randomized clinical trial.
    Alvares BA; Miola AC; Schimitt JV; Miot HA; Abbade LPF
    An Bras Dermatol; 2022; 97(2):157-165. PubMed ID: 35039206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24 months, prospective, case-control study.
    Ulrich C; Jürgensen JS; Degen A; Hackethal M; Ulrich M; Patel MJ; Eberle J; Terhorst D; Sterry W; Stockfleth E
    Br J Dermatol; 2009 Nov; 161 Suppl 3():78-84. PubMed ID: 19775361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Healthcare utilization and management of actinic keratosis in primary and secondary care: a complementary database analysis.
    Noels EC; Hollestein LM; van Egmond S; Lugtenberg M; van Nistelrooij LPJ; Bindels PJE; van der Lei J; Stern RS; Nijsten T; Wakkee M
    Br J Dermatol; 2019 Sep; 181(3):544-553. PubMed ID: 30636037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of actinic keratosis patients: a qualitative study.
    Esmann S; Jemec GB
    J Dermatolog Treat; 2007; 18(1):53-8. PubMed ID: 17365267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current therapies for actinic keratosis.
    Dianzani C; Conforti C; Giuffrida R; Corneli P; di Meo N; Farinazzo E; Moret A; Magaton Rizzi G; Zalaudek I
    Int J Dermatol; 2020 Jun; 59(6):677-684. PubMed ID: 32012240
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Actinic keratosis: do the numbers add up?
    Stanger CB
    Nurse Pract; 2009 Feb; 34(2):36-9. PubMed ID: 19155885
    [No Abstract]   [Full Text] [Related]  

  • 31. The importance of early diagnosis and treatment of actinic keratosis.
    Rigel DS; Stein Gold LF
    J Am Acad Dermatol; 2013 Jan; 68(1 Suppl 1):S20-7. PubMed ID: 23228303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Awareness of, knowledge of and attitudes to nonmelanoma skin cancer (NMSC) and actinic keratosis (AK) among physicians.
    Halpern AC; Hanson LJ
    Int J Dermatol; 2004 Sep; 43(9):638-42. PubMed ID: 15357741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A feasibility study of microwave therapy for precancerous actinic keratosis.
    Jackson DN; Hogarth FJ; Sutherland D; Holmes EM; Donnan PT; Proby CM
    Br J Dermatol; 2020 Aug; 183(2):222-230. PubMed ID: 32030723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The importance of patient-centred care to overcome barriers in the management of actinic keratosis.
    Cerio R
    J Eur Acad Dermatol Venereol; 2017 Mar; 31 Suppl 2():17-20. PubMed ID: 28263022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Daylight methyl-aminolevulinate photodynamic therapy versus ingenol mebutate for the treatment of actinic keratoses: an intraindividual comparative analysis.
    Genovese G; Fai D; Fai C; Mavilia L; Mercuri SR
    Dermatol Ther; 2016 May; 29(3):191-6. PubMed ID: 26799440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topical corticosteroid has no influence on inflammation or efficacy after ingenol mebutate treatment of grade I to III actinic keratoses (AK): A randomized clinical trial.
    Erlendsson AM; Karmisholt KE; Haak CS; Stender IM; Haedersdal M
    J Am Acad Dermatol; 2016 Apr; 74(4):709-15. PubMed ID: 26810403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [New approaches for the prevention of actinic keratosis].
    Stege H; Krutmann J
    Hautarzt; 2017 May; 68(5):354-358. PubMed ID: 28444443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [When and why treat actinic keratoses?].
    Wulf HC
    Ugeskr Laeger; 2014 Feb; 176(6A):V07130448. PubMed ID: 25347437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Needs and challenges among general practitioners in the management of actinic keratosis: a qualitative study.
    Verhoeven C; Claessens Z; Lubeek SFK; Schers HJ
    BMC Prim Care; 2023 Dec; 24(1):260. PubMed ID: 38042808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Beyond actinic keratoses: Field cancerization of the skin].
    Reygagne P; Rostain G
    Ann Dermatol Venereol; 2018 Oct; 145(10):587-592. PubMed ID: 30243819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.